• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Natural Capsules Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 4124.0
  • ISIN : INE936B01015
214.20 2 (0.80%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    211.57

  • Today’s High

    218.01

  • Open

    213.00

  • Perv Close

    212.50

  • 52W Low

    164.00

  • 52W High

    274.75

Key Indicators

  • P/E(TTM)

    32.97

  • Mar.Cap (₹Cr.)

    221.51

  • Div & Yield %

    0.00

  • Book Value(₹)

    160.83

  • Debt-Equity Ratio

    0.80

  • AGM Date

    01-Aug-2025

  • EPS

    6.49

  • P/E Ratio

    32.97

Financials Ratios

  • Debt-Equity Ratio

    0.63

  • Mar.Cap (₹Cr.)

    221.51

  • RONW (%)

    3.39

  • ROCE (%)

    5.00

Score Board

  • Equity (₹ in Cr.)

    10.34

  • BV (₹)

    160.80

  • Sales( ₹ in Cr.)

    167.94

  • NP (in Cr.)

    6.71

  • NP Var(%)

    -14.0

  • Div%

    0.0

  • CPS (₹)

    14.50

  • EPS (₹)

    6.50

  • Traded Value (₹ in Lakhs)

    221.30

  • 52 Week High

    274.75

  • 52 Week Low

    164.00

  • Price BSE

    214.0

  • Price NSE

    214.00

  • Market Capital( in Cr.)

    221.30

  • P/C Ratio

    14.70

  • P/E Ratio

    33.00

  • Price Vs.BV

    6.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 167.94 153.81 172.87 135.07 79.51 61.55
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 167.94 153.81 172.87 135.07 79.51 61.55
Other Income 4.24 3.15 1.07 0.93 2.90 0.95
Stock Adjustments 1.13 6.13 5.18 -1.81 -1.33 -0.11
Total Income 173.31 163.09 179.12 134.19 81.08 62.39
EXPENDITURE :            
Raw Materials 85.12 83.32 84.14 57.99 36.10 27.92
Power and Fuel Cost 15.83 15.19 13.75 11.90 8.51 8.16
Employee Cost 12.29 10.95 9.51 8.48 6.97 5.91
Other Manufacturing Expenses 13.65 12.58 11.79 7.57 4.45 4.53
Selling and Administration Expenses 21.76 17.70 22.86 16.87 9.73 8.99
Miscellaneous Expenses 0.94 -0.70 0.24 4.83 1.29 0.49
Employee Benefit Expenses 12.29 10.95 9.51 8.48 6.97 5.91
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 149.59 139.04 142.30 107.64 67.05 56.00
Operating Profit 23.72 24.05 36.82 26.54 14.04 6.40
Interest 6.09 5.09 3.88 2.08 0.54 0.91
Gross Profit 17.63 18.96 32.94 24.46 13.50 5.49
Depreciation 8.33 8.57 7.20 5.04 4.31 4.12
Profit Before Tax 9.30 10.39 25.74 19.42 9.19 1.37
Current Tax 1.23 1.97 5.46 4.74 2.22 0.66
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.36 0.62 1.09 0.73 0.02 -0.14
Reported Net Profit 6.71 7.81 19.20 13.95 6.95 0.86
Extraordinary Items 0.00 0.00 0.03 0.05 1.65 0.00
Adjusted Net Profit 6.71 7.81 19.17 13.90 5.30 0.86
Adjustment below Net Profit 0.00 0.00 0.00 -0.20 -0.06 -0.11
P & L Balance brought forward 81.16 74.29 55.86 42.73 36.22 36.09
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.93 0.77 0.62 0.37 0.62
P & L Balance carried down 87.87 81.16 74.29 55.86 42.73 36.22
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 10.00 10.00 10.00 6.00
Dividend Per Share(Rs) 0.00 0.00 1.00 1.00 1.00 0.60
Earnings Per Share-Unit Curr 6.49 8.36 20.70 19.90 11.15 1.38
Earnings Per Share(Adj)-Unit Curr 6.49 8.36 20.70 19.90 9.14 1.13
Book Value 160.83 141.30 133.74 118.45 99.68 89.24
Book Value(Adj)-Unit Curr 160.83 141.30 133.74 118.45 81.74 73.18

Shareholding Pattern

  • Promoter Group

    51.26%

  • Public Share Holding

    48.74%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 2,172,854 21.01 2,172,854 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 2,261 0.02 2,061 5
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,126,133 30.23 3,126,133 12
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,301,248 51.26 5,301,048 19
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 1,030,962 9.97 1,029,562 67
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 155,244 1.50 149,644 144
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 304,239 2.94 304,239 197
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 858,107 8.30 858,107 12
Individuals holding nominal share capital up to Rs. 1 lakh 2,559,014 24.75 2,461,689 8,866
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 123,726 1.20 123,726 1
Sub Total 5,039,906 48.74 4,935,581 9,292
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 10,341,154 100.00 10,236,629 9,311

Company Background

Natural Capsules LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Natural Capsules Ltd
  • BSE Code : 4124.0
  • ISIN : INE936B01015

  • Incorporation Year

    1993

  • Registered Office

    Trident Towers 4th Floor No 23
    100Feet Road Jayanagar IIBlock, Bangalore,
    Karnataka-560011

  • Telephone

    91-080-26671571/26671573/26671581

  • FAX

    91-080-26671562

  • Chairman

    C P Rangachar

  • Managing Director

    Sunil L Mundra

  • Company Secretary

  • Auditor

    P Chandrasekar LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Cameo Corporate Services Ltd
    Subramanian Building,
    1ST Floor No 1,Club House Road
    Mumbai - Chennai - 600002

Natural Capsules Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Natural Capsules 214.00 172.17 167.94 32.97 7.38
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10